Literature DB >> 2874009

Compliance and the elderly hypertensive.

T O Morgan, C Nowson, J Murphy, R Snowden.   

Abstract

In the control of chronic disease no therapeutic regimen is successful unless it is complied with. A number of studies have indicated that compliance with tablet-taking may be as low as 40%. Patients with hypertension are frequently on a number of different anti-hypertensive agents, and if they have other chronic disorders they may take as many as 10 different drugs and up to 40 tablets per day. It is therefore not surprising that compliance is poor. To achieve compliance requires education of the patient, reduction in the number of drugs and simplification of the drug regimen. Methyldopa was used in a crossover study on a once- or twice-daily basis. Blood pressure was measured at the same time each day 2 hours after the morning dose. Compliance was assessed by tablet count and by blood pressure control, which was better on once-a-day therapy. Over a 6-week period 95% of medication was taken on the once-daily compared with 84% on the twice-daily regimen. In a subsequent study atenolol once per day replaced propranolol given 3 times per day. Blood pressure was lower on atenolol and tablet compliance was 94% compared with 74% on thrice-daily propranolol therapy. In addition, many patients admitted not taking the midday dose. The effect of dietary advice was then monitored by 24-hour urine electrolytes. When advice was given superficially by the doctor, urine sodium fell from 186 mmol/day to 165 mmol/day. When seen on one occasion by a dietitian and given diet sheets, it fell from 182 to 135 mmol/day. When seen at repeated visits by the dietitian and the advice modified according to sodium excretion, urine sodium excretion fell from 188 to 83 mmol/day. Supplemental oral potassium is often given as antihypertensive medication and up to 6 tablets per day may be administered. Compliance decreased as the number of tablets increased. Compliance was 92% on 1 tablet, 83% on 2 tablets, 68% on 3 tablets, 75% on 4 tablets (usually taken as 2 tablets twice a day) and 58% when on 6 tablets per day. The compliance with diuretic-taking was 96%. When given amiloride/hydrochlorothiazide the compliance was 93% and this elevated plasma potassium more than high dose supplemental potassium. In a recent study people on 3 or more drugs for blood pressure control were placed on a low salt diet and their drugs replaced with enalapril.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874009     DOI: 10.2165/00003495-198600314-00021

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  11 in total

1.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

2.  Work-site as locus for hypertension care.

Authors:  M H Alderman; S Madhavan
Journal:  J Hypertens Suppl       Date:  1985-04

3.  Compliance and compliance-improving strategies in hypertension: the Japanese experience.

Authors:  J Fujii; A Seki
Journal:  J Hypertens Suppl       Date:  1985-04

Review 4.  Compliance: the case for objective measurement.

Authors:  H S Caron
Journal:  J Hypertens Suppl       Date:  1985-04

5.  Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

6.  Does self-measurement of blood pressure improve patient compliance in hypertension?

Authors:  D Edmonds; E Foerster; H Groth; P Greminger; W Siegenthaler; W Vetter
Journal:  J Hypertens Suppl       Date:  1985-04

7.  Role of paraprofessionals in improving compliance with antihypertensive treatment.

Authors:  A G Logan
Journal:  J Hypertens Suppl       Date:  1985-04

Review 8.  Compliance in hypertension: facts and concepts.

Authors:  T F Lüscher; H Vetter; W Siegenthaler; W Vetter
Journal:  J Hypertens Suppl       Date:  1985-04

Review 9.  Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance.

Authors:  P Ley
Journal:  J Hypertens Suppl       Date:  1985-04

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

View more
  8 in total

1.  Non-compliance with antihypertensive drug therapy: a risk factor for stroke among black hypertensives.

Authors:  M J Akpaffiong
Journal:  J Natl Med Assoc       Date:  1990-12       Impact factor: 1.798

Review 2.  Perspective on hypertension in the elderly.

Authors:  B Whitcomb; R L Byyny
Journal:  West J Med       Date:  1990-04

3.  Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort study.

Authors:  J Grégoire; Jocelyne Moisan; Remi Guibert; Antonio Ciampi; Alain Milot
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

4.  The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker.

Authors:  B Hubert; J Atkinson; M Guerret; M Hoffman; J P Devissaguet; P Maincent
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

5.  Rational use of the fixed combination of dorzolamide - timolol in the management of raised intraocular pressure and glaucoma.

Authors:  Jason Yeh; Daniel Kravitz; Brian Francis
Journal:  Clin Ophthalmol       Date:  2008-06

Review 6.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly.

Authors:  R A Reeves; J G Fodor; C I Gryfe; C Patterson; J D Spence
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

8.  Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study.

Authors:  Erik Stenberg; Yang Cao; Richard Marsk; Magnus Sundbom; Tomas Jernberg; Erik Näslund
Journal:  PLoS Med       Date:  2020-09-15       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.